关键词: ICI LCNEC combination therapy ipilimumab nivolumab radiotherapy
Mesh : AMP-Activated Protein Kinase Kinases Carcinoma, Large Cell / diagnosis genetics pathology therapy Carcinoma, Neuroendocrine / diagnosis genetics pathology therapy Chemoradiotherapy Drug Resistance, Neoplasm Etoposide / therapeutic use Humans Immune Checkpoint Inhibitors / therapeutic use Immunotherapy Ipilimumab / therapeutic use Lung Neoplasms / diagnosis genetics pathology therapy Male Middle Aged Mutation Nivolumab / therapeutic use Protein Serine-Threonine Kinases / genetics Radiosurgery Treatment Outcome beta 2-Microglobulin / genetics
来 源:
DOI:10.2217/imt-2019-0166
PDF(Sci-hub)